Total Payments
$7,129
2024 Payments
$1,983
Companies
36
Transactions
440
Medicare Patients
4,867
Medicare Billing
$689,303
Payment Breakdown by Category
Food & Beverage$7,092 (99.5%)
Education$36.98 (0.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,092 | 438 | 99.5% |
| Education | $36.98 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,803 | 116 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $846.29 | 58 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $689.17 | 46 | $0 (2024) |
| Janssen Biotech, Inc. | $470.00 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $254.12 | 18 | $0 (2024) |
| Celgene Corporation | $241.63 | 16 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $221.80 | 14 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $207.99 | 21 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $196.30 | 16 | $0 (2018) |
| PFIZER INC. | $180.52 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,983 | 107 | ABBVIE INC. ($429.77) |
| 2023 | $1,573 | 104 | ABBVIE INC. ($603.58) |
| 2022 | $923.12 | 56 | ABBVIE INC. ($335.63) |
| 2020 | $297.51 | 11 | ERBE USA Inc ($130.50) |
| 2019 | $740.13 | 46 | Takeda Pharmaceuticals U.S.A., Inc. ($241.75) |
| 2018 | $1,059 | 71 | Takeda Pharmaceuticals U.S.A., Inc. ($234.85) |
| 2017 | $552.39 | 45 | Takeda Pharmaceuticals America, Inc. ($207.99) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $14.14 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/21/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.08 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.27 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $115.07 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.58 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GALLSTONES | ||||||
| 10/18/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $15.85 | General |
| Category: GI | ||||||
| 10/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 890 | 34,549 | $1.3M | $356,367 |
| 2022 | 18 | 1,180 | 1,258 | $554,331 | $98,713 |
| 2021 | 19 | 1,495 | 1,614 | $733,350 | $123,303 |
| 2020 | 17 | 1,302 | 1,438 | $625,900 | $110,921 |
Total Patients
4,867
Total Services
38,859
Medicare Billing
$689,303
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 2 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 22 | $20,020 | $2,935 | 14.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $11,990 | $2,053 | 17.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 25 | $15,047 | $1,988 | 13.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 29 | 29 | $7,305 | $1,419 | 19.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 20 | $3,240 | $1,118 | 34.5% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,820 | $917.69 | 32.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 171 | 175 | $13,125 | $631.54 | 4.8% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 13 | 16 | $1,410 | $484.94 | 34.4% |
| 99153 | Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | Facility | 2022 | 44 | 50 | $2,500 | $374.85 | 15.0% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $14,740 | $172.83 | 1.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 147 | 148 | $190,180 | $28,455 | 15.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 249 | 326 | $57,050 | $20,351 | 35.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 158 | 158 | $61,620 | $17,820 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 179 | 197 | $50,235 | $17,451 | 34.7% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 58 | 62 | $48,980 | $6,546 | 13.4% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 112 | 113 | $81,360 | $6,214 | 7.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 53 | 54 | $17,280 | $5,674 | 32.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 99 | 99 | $107,415 | $5,529 | 5.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 19 | 19 | $17,290 | $3,235 | 18.7% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 22 | 22 | $20,020 | $3,091 | 15.4% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 11 | 11 | $11,550 | $1,703 | 14.7% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 21 | 21 | $12,810 | $1,619 | 12.6% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 18 | 18 | $4,230 | $1,320 | 31.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $3,570 | $1,074 | 30.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 16 | $2,640 | $889.92 | 33.7% |
About Dr. Christopher Morrison, M.D
Dr. Christopher Morrison, M.D is a Gastroenterology healthcare provider based in Voorhees, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1548581473.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Morrison, M.D has received a total of $7,129 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 440 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($7,092).
As a Medicare-enrolled provider, Morrison has provided services to 4,867 Medicare beneficiaries, totaling 38,859 services with total Medicare billing of $689,303. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Voorhees, NJ
- Active Since 06/15/2010
- Last Updated 10/08/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1548581473
Products in Payments
- XIFAXAN (Drug) $486.60
- RINVOQ (Biological) $441.33
- LINZESS (Drug) $378.90
- ENTYVIO (Biological) $355.48
- STELARA (Biological) $312.37
- Amitiza (Drug) $270.63
- ZEPOSIA (Drug) $261.12
- Entyvio (Biological) $258.02
- Humira (Biological) $247.42
- DUPIXENT (Biological) $239.72
- VIBERZI (Drug) $231.57
- SKYRIZI (Biological) $198.00
- Trulance (Drug) $196.30
- ZENPEP (Drug) $177.19
- DIFICID (Drug) $172.92
- Linzess (Drug) $168.35
- HUMIRA (Biological) $153.60
- RELTONE 200 MG (Drug) $150.00
- TRULANCE (Drug) $139.75
- XELJANZ (Drug) $138.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Voorhees
Dr. Sanket Patel, D.o, D.O
Gastroenterology — Payments: $39,650
Gastroenterology $39,650
Dr. Alan Mushnick, Md, MD
Gastroenterology — Payments: $26,516
Gastroenterology $26,516
Elizabeth Egan, Md, MD
Gastroenterology — Payments: $10,600
Gastroenterology $10,600
Dr. Michael Goldstein, Md, MD
Gastroenterology — Payments: $10,508
Gastroenterology $10,508
Alex Celluzzi, Do, DO
Gastroenterology — Payments: $9,192
Gastroenterology $9,192
Andrew Alloy, Do, DO
Gastroenterology — Payments: $9,041
Gastroenterology $9,041